520 related articles for article (PubMed ID: 27298516)
21. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
22. Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.
Jones VC; Birrell MA; Maher SA; Griffiths M; Grace M; O'Donnell VB; Clark SR; Belvisi MG
Br J Pharmacol; 2016 Mar; 173(6):992-1004. PubMed ID: 26639895
[TBL] [Abstract][Full Text] [Related]
23. Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.
Kinoshita A; Higashino M; Aratani Y; Kakuuchi A; Matsuya H; Ohmoto K
Bioorg Med Chem Lett; 2016 Feb; 26(3):1016-1019. PubMed ID: 26725951
[TBL] [Abstract][Full Text] [Related]
24. Role of PGE
Karaki SI; Tanaka R
J Physiol Sci; 2021 Feb; 71(1):8. PubMed ID: 33622238
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity.
Ahmad AS; Zhuang H; Echeverria V; Doré S
J Neurotrauma; 2006 Dec; 23(12):1895-903. PubMed ID: 17184197
[TBL] [Abstract][Full Text] [Related]
26. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
Okuyama T; Ishihara S; Sato H; Rumi MA; Kawashima K; Miyaoka Y; Suetsugu H; Kazumori H; Cava CF; Kadowaki Y; Fukuda R; Kinoshita Y
J Lab Clin Med; 2002 Aug; 140(2):92-102. PubMed ID: 12228765
[TBL] [Abstract][Full Text] [Related]
27. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
28. 15-Keto-PGE
Endo S; Suganami A; Fukushima K; Senoo K; Araki Y; Regan JW; Mashimo M; Tamura Y; Fujino H
J Biol Chem; 2020 Sep; 295(38):13338-13352. PubMed ID: 32727851
[TBL] [Abstract][Full Text] [Related]
29. [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
Hatae N
Yakugaku Zasshi; 2003 Oct; 123(10):837-43. PubMed ID: 14577329
[TBL] [Abstract][Full Text] [Related]
30. Endogenous prostaglandin E
Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
[TBL] [Abstract][Full Text] [Related]
31. The EP1/EP3 receptor agonist 17-pt-PGE
Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions.
Shiraishi N; Nomura T; Tanizaki H; Nakajima S; Narumiya S; Miyachi Y; Tokura Y; Kabashima K
PLoS One; 2013; 8(7):e69599. PubMed ID: 23922752
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 Stimulates EP2, Adenylate Cyclase, Phospholipase C, and Intracellular Calcium Release to Mediate Cyclic Adenosine Monophosphate Production in Dental Pulp Cells.
Chang MC; Lin SI; Lin LD; Chan CP; Lee MS; Wang TM; Jeng PY; Yeung SY; Jeng JH
J Endod; 2016 Apr; 42(4):584-8. PubMed ID: 26906242
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts.
Rieder F; Georgieva M; Schirbel A; Artinger M; Zügner A; Blank M; Brenmoehl J; Schölmerich J; Rogler G
Inflamm Bowel Dis; 2010 Sep; 16(9):1505-13. PubMed ID: 20803697
[TBL] [Abstract][Full Text] [Related]
35. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
36. Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
Konya V; Philipose S; Bálint Z; Olschewski A; Marsche G; Sturm EM; Schicho R; Peskar BA; Schuligoi R; Heinemann A
Eur J Immunol; 2011 Aug; 41(8):2379-89. PubMed ID: 21681739
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
38. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
